��ϲʿ�� News - Alzheimer's

Experts: FDA approves much-debated Alzheimer's drug panned by experts

webfull — Thu, 10 Jun 2021 14:35:58 +0000

U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration (FDA) said it granted approval to the drug from Biogen based on results that seemed “reasonably likely” to benefit Alzheimer's patients. (CTV News)

Published: 10 June 2021

��ϲʿ�� researchers identify correlation between mild behavioural impairment and Alzheimer’s

webfull — Wed, 08 Apr 2020 17:21:44 +0000

New research from ��ϲʿ�� has found that the presence and severity of mild behavioural impairment (MBI) in cognitively healthy individuals is strongly associated with the presence of amyloid plaques deposits in the brain, a hallmark of Alzheimer’s disease.

Published: 8 April 2020

��ϲʿ�� study identifies new role of major genetic risk factor in Alzheimer’s disease

webfull — Fri, 20 Dec 2019 16:04:26 +0000

For years, physicians have been aware that patients carrying the apolipoprotein ꜫ4 (APOE ꜫ4) gene are at a greater risk of developing Alzheimer’s disease. New research from ��ϲʿ�� has now found the gene plays an even greater role in dementia.

Published: 20 December 2019

Dr Gauthier interviewed for the World Alzheimer Report 2018

webfull — Fri, 30 Nov 2018 18:37:30 +0000

The World Alzheimer Report 2018, The state of the art of dementia research: New frontiers brings together 21 of the global leading lights in all areas of dementia research. Written by renowned journalist and broadcaster Christina Patterson (Time Magazine, The Guardian, The Sunday Times), this report tackles some of the complex questions surrounding dementia research. It looks at the hopes and frustrations and asks why there have been no major medical treatment breakthroughs for over 20 years.

Published: 30 November 2018

AI Could Predict Cognitive Decline Leading to Alzheimer’s Disease in the Next 5 Years

webfull — Thu, 04 Oct 2018 15:16:32 +0000

A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer’s disease.

Published: 4 October 2018

Pathway of Alzheimer’s degeneration discovered

webfull — Wed, 04 Jul 2018 15:23:16 +0000

Finding is key for future treatment and earlier diagnosis

Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of ��ϲʿ�� have used a unique approach to track brain degeneration in Alzheimer’s disease, uncovering a pathway through which degeneration spreads from one region to another.

Published: 4 July 2018

The onset of Alzheimer’s disease: the importance of family history

webfull — Mon, 26 Feb 2018 15:03:37 +0000

You’re about to turn 60, and you’re fretting. Your mother has had Alzheimer’s disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer’s, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

Published: 26 February 2018

New mechanism detected in Alzheimer’s disease

webfull — Fri, 13 Oct 2017 13:28:34 +0000

By Chris Chipello

��ϲʿ�� researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer’s disease.

Published: 13 October 2017

Could olfactory loss point to Alzheimer’s disease?

webfull — Tue, 15 Aug 2017 16:26:16 +0000

By the time you start losing your memory, it's almost too late. That's because the damage to your brain associated with Alzheimer’s disease (AD) may already have been going on for as long as twenty years. Which is why there is so much scientific interest in finding ways to detect the presence of the disease early on. Scientists now believe that simple odour identification tests may help track the progression of the disease before symptoms actually appear, particularly among those at risk.

Published: 15 August 2017

“Big Data” study discovers earliest sign of Alzheimer’s

webfull — Mon, 11 Jul 2016 15:12:59 +0000

��ϲʿ�� Newsroom

Research underlines importance of computational power in future neurological breakthrough

Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.

Published: 11 July 2016

���ϲʿ������ News - Alzheimer's